01883nas a2200229   4500000000100000008004100001653001400042653001800056653000900074653003300083653003500116653003000151653001500181653001600196653001500212100001200227700001400239245010800253856003100361300000900392520125200401       2017                            d10aTreatment10aPublic health10aNTDs10aNarrative survey instruments10amass drug administration (MDA)10aLymphatic filariasis (LF)10aGuidelines10aElimination10aCompliance1 aLynam T1 aKrentel A00aGuidelines for use of narrative survey instruments to improve MDA for lymphatic filariasis elimination.  uhttp://tinyurl.com/l3qq7ln  a1-593 a<p>Literature examining reasons why recipients take drugs offered during mass drug administration (MDA) for the elimination of lymphatic filariasis (LF) suggests that few knowledge&nbsp;indicators explain recipients’ compliance with treatment. In fact, social factors, such as personally knowing the drug distributor, being aware of the MDA before it occurs, or knowing other people who have taken the LF drugs, have a strong influence on people’s decisions to comply with treatment. Through shifting the focus from the individual to the individual’s experiences within specific social contexts we&nbsp; have&nbsp;a&nbsp;better&nbsp;chance of&nbsp;understanding&nbsp; compliance&nbsp;and&nbsp;non-compliance and hence identifying how best to intervene to improve compliance rates for different sections of the population.<br />
These guidelines outline the use of a novel tool and approach in public health research that places an individual’s situated or contextualised experience at the core of the research. Instead of asking about knowledge, this survey instrument asks individuals to recount their most recent experience with MDA and&nbsp; then asks a series of questions about&nbsp; that&nbsp; narrative (or short&nbsp;story).</p>